Literature DB >> 4251417

Immunization of mice and chinchillas against Pseudomonas aeruginosa.

P I Lusis, M A Soltys.   

Abstract

The possibility of production of an effective vaccine against Pseudomonas aeruginosa infections in fur-bearing animals was investigated. Twenty-three strains of Pseudomonas aeruginosa isolated from diseased chinchillas and mink were tested in mice for their immunogenic properties. Nineteen of these strains produced good immunity against homologous strains, and three of these produced also good immunity against heterologous strains. Of the remaining four strains two produced moderate immunity and two no immunity. It was found that 0.05% or 0.5% formalin added to suspensions of Pseudomonas aeruginosa or ultrasonification of the suspension produced better results than 0.5% phenol, 0.3% alcohol or heat at 100 degrees C for half an hour. Chinchillas vaccinated with two doses of formolized Pseudomonas aeruginosa bacterins were immune for 36 weeks after the second dose, while all controls died within 48 hours after being challenged. It was found that the protection afforded by the polyvalent bacterin extended beyond the strains included in the vaccine.A field survey on 34 ranches which included over 7,700 chinchillas showed very promising and encouraging results.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4251417      PMCID: PMC1319542     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  13 in total

1.  SURFACE INFECTION WITH PSEUDOMONAS AERUGINOSA.

Authors:  H L WALKER; A D MASON; G L RAULSTON
Journal:  Ann Surg       Date:  1964-08       Impact factor: 12.969

2.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis.

Authors:  P V LIU; Y ABE; J L BATES
Journal:  J Infect Dis       Date:  1961 Mar-Apr       Impact factor: 5.226

3.  Pseudomonas Vaccine I. Preparation and Assay.

Authors:  H F Laborde; C L de Fajardo
Journal:  J Bacteriol       Date:  1965-07       Impact factor: 3.490

4.  External otitis: production of Pseudomonas aeruginosa antibodies.

Authors:  C D Carr; A C Sonnenwirth; B H Senturia
Journal:  Ann Otol Rhinol Laryngol       Date:  1967-06       Impact factor: 1.547

5.  The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.

Authors:  P V Liu
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

6.  New immunotype schema for Pseudomonas aeruginosa based on protective antigens.

Authors:  M W Fisher; H B Devlin; F J Gnabasik
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

7.  Detoxification of an immunogenic fraction from a culture filtrate of Pseudomonas aeruginosa.

Authors:  R J Jones
Journal:  J Hyg (Lond)       Date:  1969-06

8.  Susceptibility of burned mice to Pseudomonas aeruginosa and protection by vaccination.

Authors:  R C Millican; G Evans; K Markley
Journal:  Ann Surg       Date:  1966-04       Impact factor: 12.969

9.  Sensitivity of Pseudomonas aeruginosa to normal serum and to polymyxin.

Authors:  L H Muschel; L A Ahl; M W Fisher
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

10.  Protection by vaccination against Pseudomonas infection after thermal injury.

Authors:  K Markley; E Smallman
Journal:  J Bacteriol       Date:  1968-10       Impact factor: 3.490

View more
  3 in total

1.  Pseudomonas aeruginosa otitis media and interna in a chinchilla ranch.

Authors:  Wendy L Wideman
Journal:  Can Vet J       Date:  2006-08       Impact factor: 1.008

2.  Prevalence and analysis of Pseudomonas aeruginosa in chinchillas.

Authors:  Yasuko Hirakawa; Hiraku Sasaki; Eiichi Kawamoto; Hiroki Ishikawa; Tetsuya Matsumoto; Naoki Aoyama; Koh Kawasumi; Hiromi Amao
Journal:  BMC Vet Res       Date:  2010-11-17       Impact factor: 2.741

Review 3.  In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging.

Authors:  Pinar Avci; Mahdi Karimi; Magesh Sadasivam; Wanessa C Antunes-Melo; Elisa Carrasco; Michael R Hamblin
Journal:  Virulence       Date:  2017-12-08       Impact factor: 5.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.